Industry: Chemical & Material
Published Date: 2024-01-18
Pages: 106 Pages
Report ld: 2325310
Request Sample
Customized Report
Glycerophosphorylcholine (GPC) Market Size(US$)

CAGR 2024-2030
5.7%
Market Size,2030
USD 95
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 72 million in 2023 and is forecast to a readjusted size of US$ 95 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
Global key players of Glycerophosphorylcholine (GPC) include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co and Suzhou Fushilai Pharmaceutical, etc. Global top four manufacturers hold a share over 50%. China is the largest producer of Glycerophosphorylcholine (GPC), followed by Europe.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Glycerophosphorylcholine (GPC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glycerophosphorylcholine (GPC) by region & country, by Type, and by Application.
The Glycerophosphorylcholine (GPC) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycerophosphorylcholine (GPC).
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Glycerophosphorylcholine (GPC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Glycerophosphorylcholine (GPC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Glycerophosphorylcholine (GPC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Glycerophosphorylcholine (GPC) Product Introduction
1.2 Global Glycerophosphorylcholine (GPC) Market Size Forecast
1.2.1 Global Glycerophosphorylcholine (GPC) Sales Value (2019-2030)
1.2.2 Global Glycerophosphorylcholine (GPC) Sales Volume (2019-2030)
1.2.3 Global Glycerophosphorylcholine (GPC) Sales Price (2019-2030)
1.3 Glycerophosphorylcholine (GPC) Market Trends & Drivers
1.3.1 Glycerophosphorylcholine (GPC) Industry Trends
1.3.2 Glycerophosphorylcholine (GPC) Market Drivers & Opportunity
1.3.3 Glycerophosphorylcholine (GPC) Market Challenges
1.3.4 Glycerophosphorylcholine (GPC) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glycerophosphorylcholine (GPC) Players Revenue Ranking (2023)
2.2 Global Glycerophosphorylcholine (GPC) Revenue by Company (2019-2024)
2.3 Global Glycerophosphorylcholine (GPC) Players Sales Volume Ranking (2023)
2.4 Global Glycerophosphorylcholine (GPC) Sales Volume by Company Players (2019-2024)
2.5 Global Glycerophosphorylcholine (GPC) Average Price by Company (2019-2024)
2.6 Key Manufacturers Glycerophosphorylcholine (GPC) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Glycerophosphorylcholine (GPC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Glycerophosphorylcholine (GPC)
2.9 Glycerophosphorylcholine (GPC) Market Competitive Analysis
2.9.1 Glycerophosphorylcholine (GPC) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Glycerophosphorylcholine (GPC) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycerophosphorylcholine (GPC) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid Glycerophosphorylcholine
3.1.2 Powder Glycerophosphorylcholine
3.2 Global Glycerophosphorylcholine (GPC) Sales Value by Type
3.2.1 Global Glycerophosphorylcholine (GPC) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Glycerophosphorylcholine (GPC) Sales Value, by Type (2019-2030)
3.2.3 Global Glycerophosphorylcholine (GPC) Sales Value, by Type (%) (2019-2030)
3.3 Global Glycerophosphorylcholine (GPC) Sales Volume by Type
3.3.1 Global Glycerophosphorylcholine (GPC) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Glycerophosphorylcholine (GPC) Sales Volume, by Type (2019-2030)
3.3.3 Global Glycerophosphorylcholine (GPC) Sales Volume, by Type (%) (2019-2030)
3.4 Global Glycerophosphorylcholine (GPC) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Health Products
4.2 Global Glycerophosphorylcholine (GPC) Sales Value by Application
4.2.1 Global Glycerophosphorylcholine (GPC) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Glycerophosphorylcholine (GPC) Sales Value, by Application (2019-2030)
4.2.3 Global Glycerophosphorylcholine (GPC) Sales Value, by Application (%) (2019-2030)
4.3 Global Glycerophosphorylcholine (GPC) Sales Volume by Application
4.3.1 Global Glycerophosphorylcholine (GPC) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Glycerophosphorylcholine (GPC) Sales Volume, by Application (2019-2030)
4.3.3 Global Glycerophosphorylcholine (GPC) Sales Volume, by Application (%) (2019-2030)
4.4 Global Glycerophosphorylcholine (GPC) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Glycerophosphorylcholine (GPC) Sales Value by Region
5.1.1 Global Glycerophosphorylcholine (GPC) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Glycerophosphorylcholine (GPC) Sales Value by Region (2019-2024)
5.1.3 Global Glycerophosphorylcholine (GPC) Sales Value by Region (2025-2030)
5.1.4 Global Glycerophosphorylcholine (GPC) Sales Value by Region (%), (2019-2030)
5.2 Global Glycerophosphorylcholine (GPC) Sales Volume by Region
5.2.1 Global Glycerophosphorylcholine (GPC) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Glycerophosphorylcholine (GPC) Sales Volume by Region (2019-2024)
5.2.3 Global Glycerophosphorylcholine (GPC) Sales Volume by Region (2025-2030)
5.2.4 Global Glycerophosphorylcholine (GPC) Sales Volume by Region (%), (2019-2030)
5.3 Global Glycerophosphorylcholine (GPC) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
5.4.2 North America Glycerophosphorylcholine (GPC) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
5.5.2 Europe Glycerophosphorylcholine (GPC) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
5.6.2 Asia Pacific Glycerophosphorylcholine (GPC) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
5.7.2 South America Glycerophosphorylcholine (GPC) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
5.8.2 Middle East & Africa Glycerophosphorylcholine (GPC) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glycerophosphorylcholine (GPC) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Glycerophosphorylcholine (GPC) Sales Value
6.2.1 Key Countries/Regions Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Glycerophosphorylcholine (GPC) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.3.2 United States Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.4.2 Europe Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.5.2 China Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.6.2 Japan Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.7.2 South Korea Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.8.2 Southeast Asia Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Glycerophosphorylcholine (GPC) Sales Value, 2019-2030
6.9.2 India Glycerophosphorylcholine (GPC) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Glycerophosphorylcholine (GPC) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lipoid GmbH
7.1.1 Lipoid GmbH Company Information
7.1.2 Lipoid GmbH Introduction and Business Overview
7.1.3 Lipoid GmbH Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Lipoid GmbH Glycerophosphorylcholine (GPC) Product Offerings
7.1.5 Lipoid GmbH Recent Development
7.2 Archimica SpA
7.2.1 Archimica SpA Company Information
7.2.2 Archimica SpA Introduction and Business Overview
7.2.3 Archimica SpA Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Archimica SpA Glycerophosphorylcholine (GPC) Product Offerings
7.2.5 Archimica SpA Recent Development
7.3 Jiangsu Weiqida Pharmaceutical Co
7.3.1 Jiangsu Weiqida Pharmaceutical Co Company Information
7.3.2 Jiangsu Weiqida Pharmaceutical Co Introduction and Business Overview
7.3.3 Jiangsu Weiqida Pharmaceutical Co Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Jiangsu Weiqida Pharmaceutical Co Glycerophosphorylcholine (GPC) Product Offerings
7.3.5 Jiangsu Weiqida Pharmaceutical Co Recent Development
7.4 Suzhou Fushilai Pharmaceutical
7.4.1 Suzhou Fushilai Pharmaceutical Company Information
7.4.2 Suzhou Fushilai Pharmaceutical Introduction and Business Overview
7.4.3 Suzhou Fushilai Pharmaceutical Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Suzhou Fushilai Pharmaceutical Glycerophosphorylcholine (GPC) Product Offerings
7.4.5 Suzhou Fushilai Pharmaceutical Recent Development
7.5 Foman Biopharma
7.5.1 Foman Biopharma Company Information
7.5.2 Foman Biopharma Introduction and Business Overview
7.5.3 Foman Biopharma Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Foman Biopharma Glycerophosphorylcholine (GPC) Product Offerings
7.5.5 Foman Biopharma Recent Development
7.6 JYOUKI Pharmaceutical Co
7.6.1 JYOUKI Pharmaceutical Co Company Information
7.6.2 JYOUKI Pharmaceutical Co Introduction and Business Overview
7.6.3 JYOUKI Pharmaceutical Co Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 JYOUKI Pharmaceutical Co Glycerophosphorylcholine (GPC) Product Offerings
7.6.5 JYOUKI Pharmaceutical Co Recent Development
7.7 Wuxi Cima Science Co
7.7.1 Wuxi Cima Science Co Company Information
7.7.2 Wuxi Cima Science Co Introduction and Business Overview
7.7.3 Wuxi Cima Science Co Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Wuxi Cima Science Co Glycerophosphorylcholine (GPC) Product Offerings
7.7.5 Wuxi Cima Science Co Recent Development
7.8 Changsha Jiaxi Biotechnology
7.8.1 Changsha Jiaxi Biotechnology Company Information
7.8.2 Changsha Jiaxi Biotechnology Introduction and Business Overview
7.8.3 Changsha Jiaxi Biotechnology Glycerophosphorylcholine (GPC) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Changsha Jiaxi Biotechnology Glycerophosphorylcholine (GPC) Product Offerings
7.8.5 Changsha Jiaxi Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Glycerophosphorylcholine (GPC) Industrial Chain
8.2 Glycerophosphorylcholine (GPC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Glycerophosphorylcholine (GPC) Sales Model
8.5.2 Sales Channel
8.5.3 Glycerophosphorylcholine (GPC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Glycerophosphorylcholine (GPC) market size was US$ 75.7 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 5.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 76
USD 4250.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market was valued at US$ 75.7 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 135
USD 2900.00
(Single User License)
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 75.7 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 103
USD 3950.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market size was US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 76
USD 4250.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market is projected to grow from US$ 72 million in 2024 to US$ 105 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 135
USD 4900.00
(Single User License)
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 105
USD 3950.00
(Single User License)
The global market for Glycerophosphorylcholine (GPC) was valued at US$ 72 million in the year 2024 and is projected to reach a revised size of US$ 105 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published Date: 2025-01-19
Pages: 89
USD 2900.00
(Single User License)
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published Date: 2024-01-03
Pages: 91
USD 2900.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market size was US$ 75.7 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 5.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 76
The global Glycerophosphorylcholine (GPC) market was valued at US$ 75.7 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 135
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 75.7 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 103
The global Glycerophosphorylcholine (GPC) market size was US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 76
The global Glycerophosphorylcholine (GPC) market is projected to grow from US$ 72 million in 2024 to US$ 105 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 135
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 105
The global market for Glycerophosphorylcholine (GPC) was valued at US$ 72 million in the year 2024 and is projected to reach a revised size of US$ 105 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published: 2025-01-19
Pages: 89
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published: 2024-01-03
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now